特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の成長因子(血液および組織)市場

Growth Factors (Blood and Tissue)

発行 Global Industry Analysts, Inc. 商品コード 243050
出版日 ページ情報 英文 248 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

世界の成長因子(血液および組織)市場 Growth Factors (Blood and Tissue)
出版日: 2020年07月01日 ページ情報: 英文 248 Pages
概要

当レポートでは、世界の成長因子(血液および組織)市場について分析し、米国、カナダ、日本、欧州、アジア太平洋地域、ラテンアメリカなどの地域別の動向、今後の市場予測、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 市場概要
    • 成長因子:序論
    • 世界的人口増加が大きな成長の機会
    • 高齢化:新たな効果的薬剤の必要性
    • 新興市場における医療支出の増加
    • 世界的医療支出
    • 生物製剤:急速に地位を拡大
    • エリスロポエチン(EPO)市場
    • CKDおよび癌患者における貧血
    • インターフェロン市場:特殊な治療のニーズ拡大が成長を牽引 他
  • 成長因子:概要
    • 血液成長因子
    • コロニー刺激因子
    • インターフェロン
    • インターロイキン
    • 組織成長因子
    • 創傷治療成長因子
    • 神経栄養成長因子
    • 血管内皮成長因子
    • 線維芽細胞成長因子
    • インスリン様成長因子
    • 血小板抽出成長因子
    • 成長因子:組織修復における作用機序
    • 血管形成:創傷治療における役割
    • 心臓ステントの代替策としての欠陥形成
    • 成長因子の応用
    • 成長因子:作用部位/コースと応用
  • 研究と治験
  • 製品技術革新/導入
  • 近年の業界活動
  • 主要参入企業
    • Alseres Pharmaceuticals, Inc.
    • Amgen, Inc.
    • Bayer HealthCare Pharmaceuticals, Inc.
    • Biogen Idec Inc
    • BioMimetic Therapeutics, Inc.
    • Biopharm GmbH
    • Bolder Biotechnology, Inc.
    • F. Hoffmann-La Roche Ltd
    • 中外製薬株式会社
    • Genentech, Inc.
    • FibroGen, Inc.
    • Johnson & Johnson
    • Janssen Biotech, Inc.
    • Lonza Group
    • Merck Serono International S.A.
    • NsGene A/S
    • PeproTech, Inc.
    • Reliance GeneMedix Plc
    • Sangamo BioSciences, Inc.
    • Sanofi
    • Shantha Biotechnics
    • Scil Proteins GmbH
    • Wockhardt Ltd.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • その他の諸国
目次
Product Code: MCP-1217

Global Growth Factors (Blood and Tissue) Market to Reach US$66.9 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Growth Factors (Blood and Tissue) estimated at US$42.6 Billion in the year 2020, is projected to reach a revised size of US$66.9 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027.Interferons, one of the segments analyzed in the report, is projected to grow at a 8.7% CAGR to reach US$49.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Colony Stimulating Factors segment is readjusted to a revised -1.7% CAGR for the next 7-year period. This segment currently accounts for a 14.8% share of the global Growth Factors (Blood and Tissue) market.

The U.S. Accounts for Over 27% of Global Market Size in 2020, While China is Forecast to Grow at a 10.8% CAGR for the Period of 2020-2027

The Growth Factors (Blood and Tissue) market in the U.S. is estimated at US$11.5 Billion in the year 2020. The country currently accounts for a 27.03% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$15.2 Billion in the year 2027 trailing a CAGR of 10.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR while Rest of European market (as defined in the study) will reach US$15.2 Billion by the year 2027.

Erythropoietins Segment Corners a 8.2% Share in 2020

In the global Erythropoietins segment, USA, Canada, Japan, China and Europe will drive the -2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.7 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.1 Billion by the year 2027, while Latin America will expand at a -2.8% CAGR through the analysis period. We bring years of research experience to this 17th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Amgen, Inc.
  • Bayer HealthCare Pharmaceuticals, Inc.
  • Biocon Ltd.
  • Biogen, Inc.
  • Biopharm GmbH
  • Bolder BioTechnology, Inc.
  • Chugai Pharmaceutical Co. Ltd.
  • F. Hoffmann-La Roche AG
  • FibroGen, Inc.
  • Genentech, Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • Lonza Group
  • Merck Serono
  • PeproTech, Inc.
  • Reliance GeneMedix Plc
  • Sangamo Therapeutics, Inc.
  • Sanofi
  • Scil Proteins GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Growth Factors: A Preface
  • Recent Market Activity
  • Burgeoning Global Population Offers Significant Growth Opportunities
  • Aging Global Population: Need for New Effective Drugs
  • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
  • Global Spending on Medicines: A Review
  • Biologics: Rapidly Gaining Ground
  • Erythropoietin (EPO) Market: An Insight
  • Anemia in CKD and Cancer Patients: Opportunity for EPO Therapy
  • Global Competitor Market Shares
  • Growth Factors (Blood and Tissue) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Amgen, Inc. (USA)
  • Bayer HealthCare Pharmaceuticals, Inc. (USA)
  • Biocon Ltd. (India)
  • Biogen, Inc. (USA)
  • BioMimetic Therapeutics LLC (USA)
  • Biopharm GmbH (Germany)
  • Bolder BioTechnology, Inc. (USA)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Chugai Pharmaceutical Co. Ltd. (Japan)
  • Genentech, Inc. (USA)
  • FibroGen, Inc. (USA)
  • Johnson & Johnson (USA)
  • Janssen Biotech, Inc. (USA)
  • Lonza Group (Switzerland)
  • Merck Serono (Germany)
  • PeproTech, Inc. (USA)
  • Reliance GeneMedix Plc (UK)
  • Sangamo Therapeutics, Inc. (USA)
  • Sanofi (France)
  • Scil Proteins GmbH (Germany)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Wockhardt Ltd. (India)

3. MARKET TRENDS & DRIVERS

  • Interferons Market: Rising Demand for Specialized Therapies to Drive Growth
  • Patent Expiries of Major Interferon Drugs
  • Colony Stimulating Factors (CSFs) Market in Myeloma Patients
  • Neurotrophic Therapeutics: Recent Advancements & Challenges
  • Clinical Trial Status of Neurotrophin Therapy for Major Neurodegenerative Diseases (2012)
  • Interleukin-17 Market for Psoriasis Treatment: Positive Opportunities
  • Anti-IL-6 Pathways for RA Treatment: Favorable Prospects
  • Blood Growth Factors: Improving Circulation & Mobility in Peripheral Artery Disease Patients
  • Wound Management Market and Cellular Growth Factors
  • Growth Factors for Wound Management - A Snapshot
  • Multiple Sclerosis Drugs Market: Competition Set to Intensify
  • Interferon-based Drugs for HCV Treatment: An Insight
  • Patent Expiries Fuel Competition and Sales
  • Patent Expiries of Biopharmaceuticals in Europe and United States
  • Innovative Delivery System Shows Potential for Accelerating Use of Growth Factors
  • Cytokines: Vital Growth Propellers for the Future of New Drugs
  • Brain Derived Neurotrophic Factor (BDNF) Finds Increased Application
  • Mimetic Growth Factors - Promising Potential
  • New Technologies - Challenge to Growth Factors Market
  • Influence of Neurotrophic Factors on Brain Cell Development
  • Side Effects - Still a Concern
  • Combination of Interferons and Ribavirin Develops More Anemia Cases
  • Development of Cost Effective Methods - Need of the Hour
  • hMSC-based Therapies to Drive Need for Growth Factors

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Growth Factors (Blood and Tissue) Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Growth Factors (Blood and Tissue) Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Growth Factors (Blood and Tissue) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Interferons (Growth Factor) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Interferons (Growth Factor) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Interferons (Growth Factor) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Colony Stimulating Factors (Growth Factor) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Colony Stimulating Factors (Growth Factor) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Colony Stimulating Factors (Growth Factor) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Erythropoietins (Growth Factor) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Erythropoietins (Growth Factor) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Erythropoietins (Growth Factor) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Interleukins (Growth Factor) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Interleukins (Growth Factor) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Interleukins (Growth Factor) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Other Growth Factors (Growth Factor) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Other Growth Factors (Growth Factor) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Other Growth Factors (Growth Factor) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Growth Factors (Blood and Tissue) Market Share (in %) by Company: 2018 & 2025
    • Market Analytics
    • TABLE 19: United States Growth Factors (Blood and Tissue) Market Estimates and Projections in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 20: Growth Factors (Blood and Tissue) Market in the United States by Growth Factor: A Historic Review in US$ Million for 2012-2019
    • TABLE 21: United States Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 22: Canadian Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 23: Canadian Growth Factors (Blood and Tissue) Historic Market Review by Growth Factor in US$ Million: 2012-2019
    • TABLE 24: Growth Factors (Blood and Tissue) Market in Canada: Percentage Share Breakdown of Sales by Growth Factor for 2012, 2020, and 2027
  • JAPAN
    • TABLE 25: Japanese Market for Growth Factors (Blood and Tissue): Annual Sales Estimates and Projections in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 26: Growth Factors (Blood and Tissue) Market in Japan: Historic Sales Analysis in US$ Million by Growth Factor for the Period 2012-2019
    • TABLE 27: Japanese Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 28: Chinese Growth Factors (Blood and Tissue) Market Growth Prospects in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 29: Growth Factors (Blood and Tissue) Historic Market Analysis in China in US$ Million by Growth Factor: 2012-2019
    • TABLE 30: Chinese Growth Factors (Blood and Tissue) Market by Growth Factor: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • EUROPE
    • Market Facts & Figures
    • European Growth Factors (Blood and Tissue) Market: Competitor Market Share Scenario (in %) for 2018 & 2025
    • Market Analytics
    • TABLE 31: European Growth Factors (Blood and Tissue) Market Demand Scenario in US$ Million by Region/Country: 2020-2027
    • TABLE 32: Growth Factors (Blood and Tissue) Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 33: European Growth Factors (Blood and Tissue) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 34: European Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020-2027
    • TABLE 35: Growth Factors (Blood and Tissue) Market in Europe in US$ Million by Growth Factor: A Historic Review for the Period 2012-2019
    • TABLE 36: European Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 37: Growth Factors (Blood and Tissue) Market in France by Growth Factor: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 38: French Growth Factors (Blood and Tissue) Historic Market Scenario in US$ Million by Growth Factor: 2012-2019
    • TABLE 39: French Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • GERMANY
    • TABLE 40: Growth Factors (Blood and Tissue) Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 41: German Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 42: German Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 43: Italian Growth Factors (Blood and Tissue) Market Growth Prospects in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 44: Growth Factors (Blood and Tissue) Historic Market Analysis in Italy in US$ Million by Growth Factor: 2012-2019
    • TABLE 45: Italian Growth Factors (Blood and Tissue) Market by Growth Factor: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Growth Factors (Blood and Tissue): Annual Sales Estimates and Projections in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 47: Growth Factors (Blood and Tissue) Market in the United Kingdom: Historic Sales Analysis in US$ Million by Growth Factor for the Period 2012-2019
    • TABLE 48: United Kingdom Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 49: Spanish Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 50: Spanish Growth Factors (Blood and Tissue) Historic Market Review by Growth Factor in US$ Million: 2012-2019
    • TABLE 51: Growth Factors (Blood and Tissue) Market in Spain: Percentage Share Breakdown of Sales by Growth Factor for 2012, 2020, and 2027
  • RUSSIA
    • TABLE 52: Russian Growth Factors (Blood and Tissue) Market Estimates and Projections in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 53: Growth Factors (Blood and Tissue) Market in Russia by Growth Factor: A Historic Review in US$ Million for 2012-2019
    • TABLE 54: Russian Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020-2027
    • TABLE 56: Growth Factors (Blood and Tissue) Market in Rest of Europe in US$ Million by Growth Factor: A Historic Review for the Period 2012-2019
    • TABLE 57: Rest of Europe Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 59: Growth Factors (Blood and Tissue) Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
    • TABLE 60: Asia-Pacific Growth Factors (Blood and Tissue) Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 61: Growth Factors (Blood and Tissue) Market in Asia-Pacific by Growth Factor: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 62: Asia-Pacific Growth Factors (Blood and Tissue) Historic Market Scenario in US$ Million by Growth Factor: 2012-2019
    • TABLE 63: Asia-Pacific Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • AUSTRALIA
    • TABLE 64: Growth Factors (Blood and Tissue) Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 65: Australian Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 66: Australian Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 67: Indian Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 68: Indian Growth Factors (Blood and Tissue) Historic Market Review by Growth Factor in US$ Million: 2012-2019
    • TABLE 69: Growth Factors (Blood and Tissue) Market in India: Percentage Share Breakdown of Sales by Growth Factor for 2012, 2020, and 2027
  • SOUTH KOREA
    • TABLE 70: Growth Factors (Blood and Tissue) Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 71: South Korean Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 72: Growth Factors (Blood and Tissue) Market Share Distribution in South Korea by Growth Factor: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Market for Growth Factors (Blood and Tissue): Annual Sales Estimates and Projections in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 74: Growth Factors (Blood and Tissue) Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Growth Factor for the Period 2012-2019
    • TABLE 75: Rest of Asia-Pacific Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 76: Latin American Growth Factors (Blood and Tissue) Market Trends by Region/Country in US$ Million: 2020-2027
    • TABLE 77: Growth Factors (Blood and Tissue) Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 78: Latin American Growth Factors (Blood and Tissue) Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 79: Latin American Growth Factors (Blood and Tissue) Market Growth Prospects in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 80: Growth Factors (Blood and Tissue) Historic Market Analysis in Latin America in US$ Million by Growth Factor: 2012-2019
    • TABLE 81: Latin American Growth Factors (Blood and Tissue) Market by Growth Factor: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • ARGENTINA
    • TABLE 82: Argentinean Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020-2027
    • TABLE 83: Growth Factors (Blood and Tissue) Market in Argentina in US$ Million by Growth Factor: A Historic Review for the Period 2012-2019
    • TABLE 84: Argentinean Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 85: Growth Factors (Blood and Tissue) Market in Brazil by Growth Factor: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 86: Brazilian Growth Factors (Blood and Tissue) Historic Market Scenario in US$ Million by Growth Factor: 2012-2019
    • TABLE 87: Brazilian Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • MEXICO
    • TABLE 88: Growth Factors (Blood and Tissue) Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 89: Mexican Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 90: Mexican Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Growth Factors (Blood and Tissue) Market Estimates and Projections in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 92: Growth Factors (Blood and Tissue) Market in Rest of Latin America by Growth Factor: A Historic Review in US$ Million for 2012-2019
    • TABLE 93: Rest of Latin America Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 94: The Middle East Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
    • TABLE 95: Growth Factors (Blood and Tissue) Market in the Middle East by Region/Country in US$ Million: 2012-2019
    • TABLE 96: The Middle East Growth Factors (Blood and Tissue) Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 97: The Middle East Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 98: The Middle East Growth Factors (Blood and Tissue) Historic Market by Growth Factor in US$ Million: 2012-2019
    • TABLE 99: Growth Factors (Blood and Tissue) Market in the Middle East: Percentage Share Breakdown of Sales by Growth Factor for 2012,2020, and 2027
  • IRAN
    • TABLE 100: Iranian Market for Growth Factors (Blood and Tissue): Annual Sales Estimates and Projections in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 101: Growth Factors (Blood and Tissue) Market in Iran: Historic Sales Analysis in US$ Million by Growth Factor for the Period 2012-2019
    • TABLE 102: Iranian Growth Factors (Blood and Tissue) Market Share Analysis by Growth Factor: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 103: Israeli Growth Factors (Blood and Tissue) Market Estimates and Forecasts in US$ Million by Growth Factor: 2020-2027
    • TABLE 104: Growth Factors (Blood and Tissue) Market in Israel in US$ Million by Growth Factor: A Historic Review for the Period 2012-2019
    • TABLE 105: Israeli Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabian Growth Factors (Blood and Tissue) Market Growth Prospects in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 107: Growth Factors (Blood and Tissue) Historic Market Analysis in Saudi Arabia in US$ Million by Growth Factor: 2012-2019
    • TABLE 108: Saudi Arabian Growth Factors (Blood and Tissue) Market by Growth Factor: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • UNITED ARAB EMIRATES
    • TABLE 109: Growth Factors (Blood and Tissue) Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 110: United Arab Emirates Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 111: Growth Factors (Blood and Tissue) Market Share Distribution in United Arab Emirates by Growth Factor: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 112: Growth Factors (Blood and Tissue) Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Growth Factor for the Period 2020-2027
    • TABLE 113: Rest of Middle East Growth Factors (Blood and Tissue) Historic Market Analysis in US$ Million by Growth Factor: 2012-2019
    • TABLE 114: Rest of Middle East Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 115: African Growth Factors (Blood and Tissue) Market Estimates and Projections in US$ Million by Growth Factor: 2020 to 2027
    • TABLE 116: Growth Factors (Blood and Tissue) Market in Africa by Growth Factor: A Historic Review in US$ Million for 2012-2019
    • TABLE 117: African Growth Factors (Blood and Tissue) Market Share Breakdown by Growth Factor: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 101